- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Laguna Hills Today
By the People, for the People
Adagio Medical and IQVIA Compared: Which is the Better Buy?
A critical look at the financial metrics and growth prospects of these two medical companies.
Published on Feb. 8, 2026
Got story updates? Submit your updates here. ›
IQVIA (NYSE:IQV) and Adagio Medical (NASDAQ:ADGM) are both medical companies, but which one is the better investment? This article compares the two firms across key financial metrics like revenue, earnings, valuation, and profitability to determine which is the superior business.
Why it matters
Investors looking to gain exposure to the medical technology and services sector need to understand the relative strengths and weaknesses of leading players like IQVIA and Adagio Medical. This analysis can help inform investment decisions and highlight the key factors driving growth in this dynamic industry.
The details
The analysis finds that IQVIA has higher revenue and earnings than Adagio Medical, as well as stronger institutional ownership and insider holdings. IQVIA also has a higher price-to-earnings ratio, indicating it is currently more expensive than the lower-valued Adagio Medical. However, analysts see greater upside potential in Adagio Medical's stock price compared to IQVIA. IQVIA has higher stock price volatility, with a beta of 1.37 versus 0.13 for Adagio Medical.
- The analysis is based on the latest financial data reported as of February 8, 2026.
The players
IQVIA
A leading provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry.
Adagio Medical
A developmental stage medical device company focused on ablation technologies for treating cardiac arrhythmias.
What’s next
Investors should continue to monitor the financial performance and growth prospects of both IQVIA and Adagio Medical as they evaluate which company represents the better investment opportunity.
The takeaway
This analysis highlights the tradeoffs between IQVIA's larger scale and financial strength versus Adagio Medical's greater perceived upside potential. Investors will need to weigh these factors carefully to determine which medical company best fits their investment objectives and risk tolerance.
